In this Perspective, the authors explore why medical device innovation has traditionally been geared so thoroughly toward improving performance, with little regard to cost. They argue that the changing incentives in the health care sector and the move to value-based payment models, accelerated by the implementation of the Affordable Care Act, will force device manufacturers to redirect investments from the spectacular toward the prudent, which they dub "the end of sexy." The authors explore consequences for manufacturers, investors, and policymakers.
Mattke, Soeren, Harry H. Liu, and Patrick Orr, Medical Device Innovation in the Era of the Affordable Care Act: The End of Sexy. Santa Monica, CA: RAND Corporation, 2016. https://www.rand.org/pubs/perspectives/PE176.html.
Mattke, Soeren, Harry H. Liu, and Patrick Orr, Medical Device Innovation in the Era of the Affordable Care Act: The End of Sexy, Santa Monica, Calif.: RAND Corporation, PE-176-RC, 2016. As of May 11, 2022: https://www.rand.org/pubs/perspectives/PE176.html